Two of Israel's leading health reporters chose interesting angles to their year-end articles. Hadassah is the only Israeli hospital they mention.
Sarit Rosenbloom of "Yedi'ot Acharonot" listed her choice of the ten most important medical developments in 2012. Two of them came from Hadassah, the only Israeli hospital represented. The list included – The development of new generation of medications for obesity; publication of new warnings regarding side affects of Statins as an effective medication to lower Cholesterol; no breakthrough in cancer treatment this year; the appearance of a new lethal SARS like virus – Corona; the upcoming reform in the regulation of mental health services in Israel; the case of the leaking silicon grafts for breast plastic surgeries; development of a female condom; development of an artificial nose with breathing abilities; ALS clinical trial at Hadassah and a Hadassah research that showed a sharp decline in the fertility of Israeli men sperm.
Dan Even of Ha'aretz described 2012 as "the year of stem cells", and listed several recently published research projects in the USA and Japan together with Hadassah researchers who were the first in the world to be able earlier this year to produce stem cells based on human tissues only with no animal originated components in them at all.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>